Gallic Acid and Taurine Attenuate Thiamethoxam-Induced Hepatotoxicity in Rats by Modulating SIRT-1/PGC-1α,

Sara T Elazab1, Fatmah A Safhi2, Rasha K Al-Akeel3

  • 1Department of Pharmacology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt.

Insights

Taurine (TAU) and gallic acid (GA) show promise in protecting the liver from thiamethoxam (TMX) insecticide damage. These compounds mitigate oxidative stress, inflammation, and apoptosis, offering potential therapeutic benefits against TMX-induced hepatotoxicity.

Area of Science:

  • Toxicology
  • Pharmacology
  • Biochemistry

Background:

  • Thiamethoxam (TMX), a widely used neonicotinoid insecticide, poses significant toxic risks to mammalian organs, particularly the liver.
  • Understanding the molecular mechanisms underlying TMX-induced hepatotoxicity is crucial for developing effective countermeasures.

Purpose of the Study:

  • To investigate the potential hepatoprotective effects of taurine (TAU) and gallic acid (GA) against TMX-induced liver injury in rats.
  • To elucidate the roles of TAU and GA in modulating key signaling pathways, including SIRT-1/PGC-1α, NF-κB/iNOS, and p53/Bax/caspase-3.

Main Methods:

  • Rats were administered TAU (50 mg/kg), GA (20 mg/kg), TMX (78.15 mg/kg), or combinations thereof daily for 28 days.
  • Hepatic function, histological structure, oxidative stress markers, inflammatory mediators, and apoptosis-related proteins were assessed.

Main Results:

  • TAU and/or GA significantly attenuated TMX-induced liver damage, restoring hepatic function and histological integrity.
  • These compounds mitigated oxidative stress by upregulating antioxidant defenses (SIRT-1, PGC-1α, Nrf2, HO-1) and suppressed inflammation by modulating cytokine and inflammatory pathway markers (IL-10, NF-κB, IL-1β, iNOS, NLRP3, TNF-α).
  • TAU and GA demonstrated anti-apoptotic effects by modulating Bcl-2, p53, Bax, and caspase-3 expression.

Conclusions:

  • Taurine and gallic acid exhibit significant hepatoprotective potential against thiamethoxam-induced liver toxicity.
  • Their mechanisms involve the activation of SIRT-1/PGC-1α signaling, suppression of inflammatory pathways, and reduction of apoptosis.
  • TAU and GA represent promising therapeutic agents for mitigating TMX-induced hepatotoxicity.